Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for InRetail Perú in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$29.13.
Current Consensus is
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in InRetail Perú. This rating has held steady since August 2023, when it changed from a Hold consensus rating.
InRetail Perú Corp., together with its subsidiaries, operates as a multi-format retailer primarily in Peru. The company operates through Food Retail, Pharmacies, Distribution, Shopping Malls, and Digital segments. It operates hypermarkets; pharmacies under the Inkafarma and Mifarma brand names; shopping centers under the Real Plaza brand; and supermarkets under the Plaza Vea Hiper, Plaza Vea Super, Vivanda, Makro, and Mass brand names. The company also engages in development of real estate; distribution of pharmaceutical products; commercialization of cosmetic and pharmaceutical products, as well as food for medical use; leasing of space; and provision of digital services. The company was incorporated in 2011 and is based in Lima, Peru. InRetail Perú Corp. is a subsidiary of Intercorp Retail Inc.
Read More
